Portfolio company
HTG Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
HTG Medical develops an automated urine output monitoring device for intensive care units to improve clinical data accuracy and reduce nursing workloads.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
U-Care Medical
This company develops artificial intelligence software for clinicians to predict and manage patient complications, such as acute kidney injury, within intensive care units.
GlucoSet
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
Heartfelt Technologies
Heartfelt Technologies develops an automated home-monitoring device that uses optical sensors to detect heart failure symptoms in patients by tracking changes in foot volume.
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
VSA Innovation
VSA Innovation develops an automated urine testing device for home and professional care settings to enable real-time health monitoring and disease detection.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
KidneyMetrix
The company develops an artificial intelligence platform using non-invasive sampling to provide early diagnostic insights for kidney injuries to healthcare providers.
